In order to update recommendations on treatment, supportive care, education and follow-up
of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary …

Opinion statement Recently introduced systemic therapies for locally advanced and
metastatic non-melanoma skin cancers (NMSCs) are paving the way for neoadjuvant …

Keratinocyte cancers–basal and cutaneous squamous cell carcinoma (BCC, cSCC)–are the
most common forms of non-melanoma skin cancer (NMSC) and there has been a significant …

In order to update recommendations on treatment, supportive care, education, and follow-up
of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary …

Background Cutaneous squamous‐cell carcinoma (CSCC) is among the most frequent
malignancies worldwide. For those not amenable to treatment with curative intent, immune …

Background: Treatment for locally advanced cutaneous squamous cell cancers (laCSCC)
remains poorly defined. Most laCSCC tumors express high levels of epidermal growth factor …

More than half of cancer patients are treated with radiotherapy, which kills tumor cells by
directly and indirectly inducing DNA damage, including cytotoxic DNA double-strand breaks …

Cutaneous squamous cell carcinoma (CSCC) is a common type of skin malignancy that
affects people who have been exposed to sunlight for a long time. It has been associated to …

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin
cancer. National and international associations have issued evidence‐and consensus …

Simple Summary While surgery remains the main treatment modality for non-melanoma skin
cancer (NMSC), radiotherapy still plays a major role in the treatment algorithm, even with the …